Suppr超能文献

正常受试者而非哮喘患者对吸入乙酰甲胆碱产生快速减敏反应。

Tachyphylaxis to inhaled methacholine in normal but not asthmatic subjects.

作者信息

Stevens W H, Manning P J, Watson R M, O'Byrne P M

机构信息

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

出版信息

J Appl Physiol (1985). 1990 Sep;69(3):875-9. doi: 10.1152/jappl.1990.69.3.875.

Abstract

Methacholine inhalation tests measure airway responsiveness in asthmatic and normal subjects. Tachyphylaxis occurs with repeated methacholine inhalations in normal subjects. The purpose of this study was to examine the time course and mechanisms of methacholine tachyphylaxis in normal subjects and to determine whether this occurs in mildly asthmatic subjects. Fifteen normal and nine asthmatic subjects were studied on 2 study days, at least 48 h apart. Each day, two inhalation tests were carried out. On one day, subjects performed two methacholine inhalation tests 3 h later by a methacholine test. Results were expressed as the provocation concentration causing a 20% fall in forced expiratory volume in 1 s (FEV1), (PC20). All normal subjects developed methacholine tachyphylaxis. The mean PC20 increased from 47.3 mg/ml (%SE 1.34) to 115.6 (%SE 1.51) (P less than 0.0001) in a 3-h interval. This increase lasted for greater than or equal to 6 h (P = 0.012). Asthmatic subjects did not develop methacholine tachyphylaxis. Their mean methacholine PC20s were 1.6 mg/ml (%SE 1.4) and 1.5 (%SE 1.4) (P = 0.75) 3 h later. In two other series of experiments, normal subjects were pretreated with the cyclooxygenase inhibitors indomethacin (100 mg/day) or flurbiprofen (150 mg/day) or a placebo for 3 days before two methacholine tests 3 h apart. Both indomethacin and flurbiprofen significantly inhibited the development of methacholine tachyphylaxis. These results confirm that methacholine tachyphylaxis occurs in normal subjects, lasts greater than or equal to 6 h, and may occur through the release of inhibitory prostaglandins. By contrast, methacholine tachyphylaxis does not occur in asthmatic subjects.

摘要

乙酰甲胆碱吸入试验可测量哮喘患者和正常受试者的气道反应性。正常受试者反复吸入乙酰甲胆碱会出现快速减敏现象。本研究的目的是研究正常受试者中乙酰甲胆碱快速减敏的时间进程和机制,并确定轻度哮喘患者是否也会出现这种情况。15名正常受试者和9名哮喘患者在两个研究日进行了研究,间隔至少48小时。每天进行两次吸入试验。在其中一天,受试者在3小时后通过乙酰甲胆碱试验进行两次乙酰甲胆碱吸入试验。结果以引起1秒用力呼气量(FEV1)下降20%的激发浓度(PC20)表示。所有正常受试者均出现了乙酰甲胆碱快速减敏现象。在3小时的间隔内,平均PC20从47.3毫克/毫升(%标准误1.34)增加到115.6(%标准误1.51)(P<0.0001)。这种增加持续≥6小时(P=0.012)。哮喘患者未出现乙酰甲胆碱快速减敏现象。3小时后,他们的平均乙酰甲胆碱PC20分别为1.6毫克/毫升(%标准误1.4)和1.5(%标准误1.4)(P=0.75)。在另外两个系列的实验中,正常受试者在间隔3小时的两次乙酰甲胆碱试验前3天,分别用环氧化酶抑制剂吲哚美辛(100毫克/天)或氟比洛芬(150毫克/天)或安慰剂进行预处理。吲哚美辛和氟比洛芬均显著抑制了乙酰甲胆碱快速减敏现象的发生。这些结果证实,乙酰甲胆碱快速减敏现象在正常受试者中出现,持续≥6小时,可能是通过抑制性前列腺素的释放而发生的。相比之下,哮喘患者不会出现乙酰甲胆碱快速减敏现象。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验